Active, Not Recruiting
A Multi-center Open-label Phase 2 Study of Ixazomib, Iberdomide and Dexamethasone in Elderly Patients With Multiple Myeloma at First Relapse."
NCT04998786
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- CHR Annecy, France
- CH de la cote basque Bayonne, France
- CHRU Hopital Haut Lévêque Bordeaux, France
- CHU Caen, France